T 0031/18 (HIGH DRUG LOAD TABLET/Novartis AG, Novartis Pharma GmbH) of 26.11.2019

European Case Law Identifier: ECLI:EP:BA:2019:T003118.20191126
Date of decision: 26 November 2019
Case number: T 0031/18
Petition for review of: -
Application number: 03722519.0
IPC class: A61K 47/32 A61K 9/26 A61K 31/505 A61K 47/38 A61K 9/28 A61K 9/16
Language of proceedings: English
Distribution: No distribution (D)
Download: Decision in English
OJ versions: No OJ links found
Other decisions for this case: -
Abstracts for this decision: -
Application title: HIGH DRUG LOAD TABLET
Applicant name: Novartis AG
Novartis Pharma GmbH
Opponent name: Actavis Group hf.
Synthon B.V./Genthon B.V.
CHEMAGIS LTD.
Teva Pharmaceutical Industries Ltd. et al.
Hightone Management Limited
Bucks
Teresa Anne
Instytut Farmaceutyczny
Ratiopharm GmbH
Zentiva a.s.
Accord Healthcare
Board: 3.3.07
Headnote: -
Relevant legal provisions: European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 13(1)
Keywords: Admission of late filed documents (No)
All requests - Inventive step (no)
Experiments submitted after the filing date as evidence for inventive step - Taken in consideration (yes)
Catchword: -
Cited cases: T 0571/11
Citing cases: G 0002/21 T 0116/18

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The patent is revoked.